Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/24/18
End: 01/10/24
Due: 01/10/25
Phase: N/A
Priority: Normal
Start: 07/22/19
End: 05/31/26
Due: 05/31/27
Phase: N/A
Priority: Normal
Start: 11/30/15
End: 07/31/19
Due: 07/31/20
Phase: N/A
Priority: Normal
Start: 07/31/14
End: 09/04/17
Due: 09/04/18
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| The TARGET BP OFF-MED Trial | NCT03503773 | Ablative Solutions, Inc. | user2@example.com | None | 2018-09-24 | 2024-01-10 | 2025-01-10 | - | - | 2025-07-14 |
| TARGET BP I Clinical Trial | NCT02910414 | Ablative Solutions, Inc. | user2@example.com | None | 2019-07-22 | 2026-05-31 | 2027-05-31 | - | - | 2025-07-14 |
| The Peregrine Post-Market Study for the Treatment of Hypertension | NCT02570113 | Ablative Solutions, Inc. | user2@example.com | None | 2015-11-30 | 2019-07-31 | 2020-07-31 | - | - | 2025-07-14 |
| The Peregrine Study: A Safety and Performance Study of Renal Denervation | NCT02155790 | Ablative Solutions, Inc. | user2@example.com | None | 2014-07-31 | 2017-09-04 | 2018-09-04 | - | - | 2025-07-14 |